BASSO, MONICA
BASSO, MONICA
Dipartimento di Medicina Molecolare - DMM
The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer.
1999 Setti, M; Bignardi, D; Ballestrero, A; Ferrando, F; Musselli, C; Blanchi, S; Basso, Monica; Bosco, O; Balleari, E; Patrone, F; Indiveri, F.
Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
2004 Cutolo, M; Pizzorni, C; Tuccio, M; Burroni, A; Craviotto, C; Basso, Monica; Seriolo, B; Sulli, A.
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.
2004 Torre, F; Rossol, S; Pelli, N; Basso, Monica; Delfino, A; Picciotto, A.
[Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement].
2004 Sulli, A; Burroni, A; Tuccio, M; Pizzorni, C; Craviotto, C; Ghio, M; Basso, Monica; Seriolo, B; Cutolo, M.
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant.
2004 Torre, F; Mattioli, F; Campo, N; Delfino, A; Basso, Monica; Pelli, N; Martelli, A; Picciotto, A.
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation.
2005 Filaci, G; Rizzi, M; Setti, M; Fenoglio, D; Fravega, M; Basso, Monica; Ansaldo, G; Ceppa, P; Borgonovo, G; Murdaca, G; Ferrera, F; Picciotto, A; Fiocca, R; Torre, G; Indiveri, F.
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin.
2006 Ciancio, A; Picciotto, A; Giordanino, C; Smedile, A; Tabone, M; Manca, A; Marenco, G; Garbagnoli, P; Andreoni, M; Cariti, G; Calleri, G; Sartori, M; Cusumano, S; Grasso, A; Rizzi, R; Gallo, M; Basso, Monica; Anselmo, M; Percario, G; Ciccone, G; Rizzetto, M; Saracco, G.
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C.
2006 Pelli, N; Torre, F; Delfino, A; Basso, Monica; Picciotto, A.
Frequency of telomerase-specific CD8+ T lymphocytes in patients with cancer.
2006 Filaci, G; Fravega, M; Setti, M; Traverso, P; Millo, E; Fenoglio, D; Negrini, S; Ferrera, F; Romagnoli, A; Basso, Monica; Contini, P; Rizzi, M; Ghio, M; Benatti, U; Damonte, G; Ravetti, Jl; Carmignani, G; Zanetti, M; Indiveri, F.
Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients.
2007 Basso, Monica; Torre, F; Grasso, A; Percario, G; Azzola, E; Artioli, S; Blanchi, S; Pelli, N; Picciotto, A.
Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.
2007 De Maria, A; Fogli, M; Mazza, S; Basso, Monica; Picciotto, A; Costa, P; Congia, S; Mingari, Mc; Moretta, L.
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumor necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.
2007 Pelli, N; Floreani, Annarosa; Torre, F; Delfino, A; Baragiotta, A; Contini, P; Basso, Monica; Picciotto, A.
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.
2007 N., Pelli; Floreani, Annarosa; F., Torre; A., Delfino; A., Baragiotta; P., Contini; Basso, Monica; A., Picciotto
Peripheral blood serum markers for apoptosis and liver fibrosis: are they trustworthy indicators of liver realness?
2008 Torre, F; Bellis, L; Delfino, A; Pelli, N; Contini, P; Basso, Monica; Puoti, C; Picciotto, A.
Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C
2008 Gabriele, Zoppoli; Giovanni Di, Maio; Stefania, Artioli; Cristina, Robaudo; Basso, Monica; Francesco, Torre; Giuseppe, Cannella; Antonino, Picciotto
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: A region-wide survey in Italy.
2009 Giannini, Eg; Torre, F; Basso, Monica; Feasi, M; Boni, S; Grasso, A; De Leo, P; Dodi, F; Marazzi, Mg; Azzola, E; Bartolacci, V; Percario, G; Beltrame, A; Borro, P; Savarino, V; Picciotto, A; Ligurian Hepatitis B., Virus Study Group
Predictive value of on-treatment response during full-dose antiviral therapy of patients with hepatitis C virus cirrhosis and portal hypertension.
2009 Giannini, Eg; Basso, Monica; Savarino, V; Picciotto, A.
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden.
2009 Torre, F; Basso, Monica; Giannini, Eg; Feasi, M; Boni, S; Grasso, A; De Leo, P; Dodi, F; Marazzi, Mg; Azzola, E; Bartolacci, V; Percario, G; Beltrame, A; Borro, P; Picciotto, A; Ligurian HBV Study, Group
Elevations in alanine aminotransferase levels late in the course of antiviral therapy in hepatitis C virus RNA-negative patients are associated with virological relapse.
2009 Basso, Monica; Giannini, Eg; Torre, F; Blanchi, S; Savarino, V; Picciotto, A.
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients.
2010 Giannini, Eg; Basso, Monica; Savarino, V; Picciotto, A.